| abstract |
The invention discloses a secreted polypeptide which was found downregulated in the CSF of Alzheimer's disease patients, which has been shown to be CSF-specific, and which has therapeutic applications for the treatment of neurological disorders. The invention also provides methods of using compositions of the invention, including the polypeptides and polynucleotides encoding them, for drug development. |